SCRI-Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
SCRI-Colorado Blood Cancer Institute has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: AML, MDS, Acute Myeloid Leukemia.
Sponsors: TScan Therapeutics, Inc., Novartis Pharmaceuticals, March Biosciences Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Colorado · View every site in Denver
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI-Colorado Blood Cancer Institute has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI-Colorado Blood Cancer Institute has 5 clinical trials on record, with 3 currently active. Their work covers AML, MDS, Acute Myeloid Leukemia.
SCRI-Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.